Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-03-02 | ||||||
REV |
Q3 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | ||||||
REV | 11.753M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
SRNE | Sorrento Therapeutics | 9.90 | 0.40 | 4.21% | 2.7B |
You can purchase shares of Sorrento Therapeutics (NASDAQ: SRNE) through any online brokerage.
Other companies in Sorrento Therapeutics’s space includes: Zentalis Pharmaceuticals (NASDAQ:ZNTL), Karuna Therapeutics (NASDAQ:KRTX) and Replimune Group (NASDAQ:REPL).
The latest price target for Sorrento Therapeutics (NASDAQ: SRNE) was reported by HC Wainwright & Co. on 2020-07-31. The analyst firm set a price target for 30.00 expecting SRNE to rise to within 12 months (a possible 203.03% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Sorrento Therapeutics (NASDAQ: SRNE) is $9.9 last updated Today at 2:36:25 PM.
There are no upcoming dividends for Sorrento Therapeutics.
There is no upcoming split for Sorrento Therapeutics.